RHReetta Holma

Reetta Holma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Reetta Holma has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Riitta Korpela

    Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland

    6 shared publications
  • Herman Adlercreutz

    Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center, and Division of Clinical Chemistry, Biomedicum, FIN-00014 University of Helsinki, Finland

    2 shared publications
  • Katja Hatakka

    Valio Limited, R&D, PO Box 30, FIN-00039 Helsinki, Finland

    2 shared publications
  • Riina A. Kekkonen

    Valio Limited, R&D, PO Box 30, FIN-00039 Helsinki, Finland

    2 shared publications
  • Tuija Poussa

    STAT-Consulting, Vahverokatu 6, FIN-37130 Nokia, Finland

    2 shared publications
  • Hanna Ventola

    Institute of Biomedicine, Pharmacology, University of Helsinki, FI-00014 Helsinki, Finland

    1 shared publication

Latest Publications

  • Open Access

    Deoxycholic acid induced changes in electrophysiological parameters and macromolecular permeability in murine small intestine with and without functional enteric nervous system plexuses

    by R. A. Forsgård, R. Korpela, L. K. Stenman, P. Österlund, R. Holma

    Background: We have previously shown in mice that the fecal proportion and concentration of the hydrophobic bile acid deoxycholic acid (DCA) is elevated with high‐fat feeding and that these changes are able to disrupt the intestinal barrier function. The aim of this study was to investigate whether these changes are mediated by the enteric nervous system (ENS).Methods: The function of theENSin the small intestinal tissues of mice was compromised by two different methods: by removing the seromuscular layer and by incubating the intact tissues with tetrodotoxin (TTX), a neural conduction blocker, beforeDCAtreatment. Tissues with or without functional plexuses were mounted into aUssing chamber system and treated with 3 mMDCAfor 20 min. AfterDCAtreatment, the intestinal permeability to fluorescein was assessed. Short‐circuit current (Isc) and transepithelial resistance (TER) were recorded throughout the experiment.Key Results: DCAincreased intestinal fluorescein permeability only in tissues where the seromuscular layer was removed. In tissues with intact seromuscular layer,DCAinduced a significant increase inTER, which was attenuated by blocking of the neural function byTTX.Conclusions & Inferences: The results of this study suggest that theDCA‐induced increase observed in fluorescein permeability is not mediated through neural pathways, but more due to a direct effect on the epithelium. However, asTTXwas able to attenuate theDCA‐induced increase inTER, it can be speculated thatDCAis also able to elicit responses through neural pathways.


  • Open Access

    Low serum enterolactone concentration is associated with low colonicLactobacillus–Enterococcuscounts in men but is not affected by a synbiotic mixture in a randomised, placebo-controlled, double-blind, cross-over intervention study

    by Reetta Holma, Riina A. Kekkonen, Katja Hatakka, Tuija Poussa, Heikki Vapaatalo, Herman Adlercreutz, Riitta Korpela

    The aims of the present study were to assess the possible differences in faecal microbiota between men with a low serum enterolactone concentration and those with a high concentration, and to investigate the impact of a synbiotic mixture on serum enterolactone concentration in men with a low concentration. We compared faecal microbiota between ten men with the lowest serum enterolactone concentration and ten men with the highest concentration at recruitment (n84). Furthermore, we carried out a randomised, double-blind, placebo-controlled, cross-over intervention study (6-week intervention periods and 4-week washout period) to investigate the impact of a synbiotic mixture (twoLactobacillusstrains, oneBifidobacteriumstrain, onePropionibacteriumstrain and galacto-oligosaccharides (32 g/l)) on serum enterolactone concentration in fifty-two men who had a concentration < 20 nmol/l. Serum sensitive C-reactive protein (CRP) concentration was measured at the end of the first intervention period. Men with a low serum enterolactone concentration when compared with those with a high concentration had less faecal bacteria, especially those belonging to theLactobacillus–Enterococcusgroup (median 8·2 (interquartile range 7·8–8·4) log10colony-forming units/gv.median 8·8 (interquartile range 8·5–8·9) log10colony-forming units/g,P= 0·009). The synbiotic mixture that was used did not have a significant effect on serum enterolactone (synbioticv.placebo ratio 0·96 (95 % CI 0·76, 1·22),P= 0·724) or serum sensitive CRP (synbioticv.placebo ratio 0·99 (95 % CI 0·74, 1·33),P= 0·954) concentration. Men with a low serum enterolactone concentration harbour less colonic bacteria, especially those belonging to theLactobacillus–Enterococcusgroup. A synbiotic mixture does not increase serum enterolactone concentration.


  • Open Access

    Effects of the viability ofLactobacillus rhamnosusGG on rotavirus infection in neonatal rats

    by Hanna Ventola, Liisa Lehtoranta, Mari Madetoja, Marja-Leena Simonen-Tikka, Leena Maunula, Merja Roivainen, Riitta Korpela, Reetta Holma

    To study the effects of live and dead Lactobacillus rhamnosus GG (GG) on rotavirus infection in a neonatal rat model. At the age of 2 d, suckling Lewis rat pups were supplemented with either live or dead GG and the treatment was continued daily throughout the experiment. At the age of 5 and 6 d the pups received oral rotavirus (RV) SA-11 strain. The pups were sacrificed at the age of 7 or 8 d by decapitation. The gastrointestinal tract was removed and macroscopic observations were done. The consistency of feces in the colon was classified using a four-tier system. RV was detected from the plasma, small intestine, colon and feces by real-time quantitative polymerase chain reaction (PCR). In this neonatal rat model, RV induced a mild-to-moderate diarrhea in all except one pup of the RV-inoculated rats. RV moderately reduced body weight development from day 6 onwards. On day 7, after 2 d of RV infection, live and dead GG groups gained significantly more weight than the RV group without probiotics [36% (P = 0.001) and 28% (P = 0.031), respectively]. In addition, when compared with the RV control group, both live and dead GG reduced the weight ratio of colon/animal body weight to the same level as in the healthy control group, with reductions of 22% (P = 0.002) and 28% (P < 0.001), respectively. Diarrhea increased moderately in both GG groups. However, the diarrhea incidence and severity in the GG groups were not statistically significantly different as compared with the RV control group. Moreover, observed diarrhea did not provoke weight loss or death. The RV control group had the largest amount of RV PCR-positive samples among the RV-infected groups, and the live GG group had the smallest amount. Rats receiving live GG had significantly less RV in the colon (P = 0.027) when compared with the RV control group. Live GG was also more effective over dead GG in reducing the quantity of RV from plasma (P = 0.047). Both live and dead GG have beneficial effects in RV infection. GG may increase RV clearance from the body and reduce colon swelling.


  • Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon

    by Reetta Holma, Pia Osterlund, Ulla Sairanen, Mikko Blom, Merja Rautio, Riitta Korpela

    Purpose We compared colonic methanogenesis in vivo and in vitro as well as fecal pH in healthy subjects and in patients with resected colorectal cancer thus without the possible confounding effects of the tumor. Methods A total of 144 subjects, 96 with resected colorectal cancer (of whom, 48 were with metastatic disease), 48 healthy subjects with intact colon, were analyzed for breath methane, fecal methanogenesis in vitro and fecal pH. In addition, the association between methanogenesis and pH with cancer site, operation technique and abdominal discomfort was investigated. Results In vivo and in vitro methane measurements were in agreement. The percentage of breath methane excretors and fecal pH did not significantly differ in participants resected for colorectal cancer, either with (46%, 6.76) or without (46%, 6.77) metastatic disease, from healthy participants (40%, 6.80). Breath methane excretors had higher fecal pH than nonexcretors (7.05 versus 6.57, P < 0.001) and less abdominal discomfort (30% versus 54%, P = 0.016). Among patients with resected right-sided cancer (n = 15), there were less breath methane excretors (20%) than among those with resected left-sided cancer (51%, n = 81, P = 0.029) as well as lower fecal pH than among those with resected left-sided cancer (6.27 versus 6.86, P = 0.002) and among healthy subjects (6.80, P = 0.010). Conclusions Patients with resected colorectal cancer were as frequently methane producers as healthy subjects with intact colon, and there was no difference in their fecal pH. Low methanogenesis was found in patients with abdominal discomfort and is a possible characteristic, along with low fecal pH, to right-sided colorectal cancer.


  • Open Access

    A Probiotic Mixture Including Galactooligosaccharides Decreases Fecal β-Glucosidase Activity but Does Not Affect Serum Enterolactone Concentration in Men during a Two-Week Intervention1–3

    by Riina A. Kekkonen, Reetta Holma, Katja Hatakka, Tarja Suomalainen, Tuija Poussa, Herman Adlercreutz, Riitta Korpela

    A high serum concentration of enterolactone, an enterolignan produced by colonic microbiota from precursors in cereals, vegetables, and fruits, is as


  • Open Access

    Constipation Is Relieved More by Rye Bread Than Wheat Bread or Laxatives without Increased Adverse Gastrointestinal Effects ,

    by Reetta Holma, Sanna-Maria Hongisto, Maija Saxelin, Riitta Korpela

    Rye bread and lactobacilli modify the colonic environment and have the potential to relieve constipation and could be a safe and convenient alternati